Document is current

Any future updates will be listed below

ECHELON-2 — brentuximab raises PTCL outcomes to new levels

Crossref DOI link: https://doi.org/10.1038/s41571-018-0163-3

Published Online: 2019-01-02

Published Print: 2019-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark